Who we are
Led by families. Built for change.
SATB2 Europe is led by parents and caregivers whose lives have been shaped by SAS. We know the challenges, the uncertainty, and the strength it takes, because this is our daily reality. Our children are at the heart of everything we do. United by love and determination, we come together to create a different future – one with better care, meaningful treatments, and greater independence for all living with SAS.
Find out more
What is SAS?
SATB2-Associated Syndrome (SAS) is a rare genetic disorder caused by changes in the SATB2 gene. This gene provides instructions for making the SATB2 protein (shown above), which plays an essential role in the development of the brain, jaw, teeth, and bones.
As a result, people with SAS may have intellectual disability, limited or absent speech, behavioural differences, dental abnormalities, and an increased risk of fractures along with a range of other features.
Despite these challenges, individuals with SAS are known for their friendly personalities and unique smiles.
Donate nowS t a t s
What we do
We turn lived experience to action, connection and lasting change for affected families across Europe and beyond. Learn more about the three initiatives that shape everything we do:
O u r m i l e s t o n e s
How far we’ve come
- 2020
- Our founders met for the first time
- 2021
- Established SATB2 Europe as a foundation
- Arranged our first SATB2 Virtual Research Roundtable
- 2022
- Sent out newsletters in 7 different languages
- Became members of Eurordis
- 2023
- Organised our second Virtual Research Round Table
- 2024
- Initiated clinical guideline work for SAS with ERN Ithaca
- 2025
- Formally established the Expert Center for SAS at Nijmegen
- Launched a SAS ambassadors’ network in Europe
- Got accepted into Rare Disease Factory program at CCP
- 2026
- Started the first drug-repurposing project for SAS
- Landed an ERDERA networking support scheme grant
- Organised clinical consensus meeting in Slovenia with 50+ clinicians and 15+ parents
Help us improve SAS lives!
Every person with SAS deserves the chance to enjoy better health, receive the right medical assistance and live a more independent life. That's why we promote research and build the foundation of accessible, clinical care.
Your support helps us improve the lives of people with SAS and give their families urgently needed hope. Every donation brings us closer to effective therapies, appropriate care and treatments that ultimately can reverse SAS symptoms.
Frequently asked questions
Simple answers for families, supporters, and professionals who want to learn more about SAS and SATB2 Europe.
What is SATB2-associated syndrome?
SATB2-associated syndrome, or SAS, is a rare genetic neurodevelopmental condition caused by changes in the SATB2 gene. It can affect development, speech, learning, behavior, dental health, sleep, seizures, feeding, and bone health.
What are common signs of SAS?
Common features can include developmental delay, limited or absent speech, dental differences, feeding difficulties, sleep challenges, behavioral differences, seizures, and bone health concerns. Not every person has the same symptoms, and the severity can vary widely.
How is SAS diagnosed?
SAS is usually diagnosed through genetic testing. A diagnosis is made when a disease-causing change, deletion, duplication, or disruption involving the SATB2 gene is found. Families should discuss testing and results with a qualified medical professional or genetic counselor.
Is there a cure for SAS?
There is currently no simple cure for SAS. Care usually focuses on supporting development, communication, feeding, sleep, seizures, dental health, bone health, and other individual needs. Research and clinical guidance are important parts of improving future care.